Home >> Biotechnology >> Consumer Goods >>

Global Gene TherapyMarket Segments and By Region Global Industry Analysis on Growth Size Share Trends and Forecast (2019-2025)

Published: Jan-2020 | Format: PDF | Facts & Factors | Code: MRS - 708684

With the use of trusted market research methodologies our research analysts have concluded that the Gene Therapymarket size in terms of value is USD Million/Billion by 2025. The unparalleled level of in-depth study showcases the market dynamics. The Gene Therapy market report also deals with the latest breakthroughs taking place in the respective business domains. 
Our trusted proprietary tools and analyst views help in categorizing the trends that will stay in the long run or will be seen in the forecast period. The Gene Therapy market report focuses extensively on analyses of the key business models, major business strategies, and respective market share of few of the most prominent players in the competitive landscape. 
The report includes Porter’s Five Forces to analyze the competitive market forces and SWOT analysis to identify the strengths, weaknesses, opportunities, and threats of the market and/or of the organizations to evaluate its core potential. PESTEL analysis is incorporated for analyzing & monitoring macro-environmental factors impacting firm’s performance. These three tools account for macro & micro factors which directly or indirectly affect the Gene Therapymarket at present as well as during the forecast period.
The study also featuremajorstrategic developments taking place in the Gene Therapymarket including research & development, acquisitions & mergers, agreements, partnerships, new service launches, and collaborations & joint ventures. The report provides an insight into the competitive moves adopted by the major market players to gain competitive advantage.
Current approvals of gene therapy products across the U.S. as well as European countries for treating a spectrum of life-threatening diseases are set to accelerate the expansion of gene therapy industry over the forecast timeline. Apparently, gene therapy can also be used for treatment pf neurodegenerative ailments like amyotrophic lateral sclerosis, Alzheimer, and spinal muscular atrophy.

Comprehensive information of the key players in the Gene Therapymarket is discussed in detail in the report. 
The report also includes:
• Analysis of the global market trends during the forecast period from 2019 to 2025 with 2018 being the base year 
• Historical data of the market is provided of years 2015, 2016, and 2017
• The report provides the dominating segments in the Gene Therapymarket 
• The report has profiled details of the key industry players in the Gene Therapy market such as Advanced Cell & Gene Therapy, Audentes Therapeutics, BenitecBiopharma, Biogen, Blubird Bio, Inc., Bristol-Myers Squibb Company, CHIESI Farmaceutici SPA, Eurofins Scientific, Geneta Science, Genzyme Corporation, Gilead, GlaxoSmithKline PLC, Human Stem Cells institute, Novartis AG, Orchard Therapeutics, Pfizer Inc., Sangamo therapeutics, Spark therapeutics, and Voyager Therapeutics.

This report segments the gene therapy market as follows:
Global Gene TherapyMarket: By TypeSegment Analysis
• Germ Line Gene Therapy
• Somatic Gene Therapy
o Ex Vivo Gene Therapy
o In Vivo Gene Therapy
Global Gene TherapyMarket: By Vector Type Segment Analysis
• Viral Vectors
o Adenoviruses 
o Retroviruses 
o Alphaviruses
o Adeno- Associated Virus 
o Herpes Simplex Virus 
o Vaccinia Viruses 
o Others (Lentivirus, Vaccinia Virus, Etc.)
• Non-Viral Vectors
o Naked DNA 
o Oligonucleotides 
o Lipoplexes and Polyplexes
• Human Artificial Chromosome
Global Gene TherapyMarket: By Therapy Area Segment Analysis
• Cancer
• Neurological Diseases
• Infectious Diseases
• Genetic Disorders
• Rheumatoid Arthritis
• Others

Global Gene TherapyMarket: Regional Segment Analysis
• North America
o The U.S. 
o Canada
o Mexico
o Rest of North America
• Europe
o France
o The UK
o Spain
o Germany
o Italy
o Nordic Countries
 Denmark
 Finland
 Iceland
 Sweden
 Norway
o Benelux Union
 Belgium
 The Netherlands
 Luxembourg
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o New Zealand
o Australia
o South Korea
o Southeast Asia
 Indonesia
 Thailand
 Malaysia
 Singapore
 Rest of Southeast Asia
o Rest of Asia Pacific
• The Middle East & Africa
o Saudi Arabia
o UAE
o Egypt
o Kuwait
o South Africa
o Rest of Middle East & Africa
• Latin America
o Brazil
o Argentina
o Rest of Latin America

Key Pointers Addressed by the Report
• Historical data and forecast analysis of the market
• Drivers and Restraints affecting market dynamics
• Exhaustive analysis about the future market trends 
• Comprehensive information about the leading market segments and region
• Strategic developments made by the competitive players and in-depth analysis about its impact on market growth
CHAPTER 1. Executive Summary 23
CHAPTER 2. Gene Therapy market – Type Analysis 25
2.1. Global Gene Therapy Market – Type Overview 25
2.2. Global Gene Therapy Market Share, by Type, 2018 & 2025 (USD Million) 25
2.3. Germ line Gene Therapy 27
2.3.1. Global Germ line Gene Therapy Gene Therapy Market, 2016-2026 (USD Million) 27
2.4. Somatic Gene Therapy 28
2.4.1. Global Somatic Gene Therapy Gene Therapy Market, 2016-2026 (USD Million) 28
CHAPTER 3. Gene Therapy market – Vector Type Analysis 28
3.1. Global Gene Therapy Market – Vector Type Overview 28
3.2. Global Gene Therapy Market Share, by Vector Type, 2018 & 2025 (USD Million) 29
3.3. Viral Vectors 30
3.3.1. Global Viral Vectors Gene Therapy Market, 2016-2026 (USD Million) 30
3.4. Non Viral Vectors 31
3.4.1. Global Non Viral Vectors Gene Therapy Market, 2016-2026 (USD Million) 31
3.5. Human Artificial Chromosome 32
3.5.1. Global Human Artificial Chromosome Gene Therapy Market, 2016-2026 (USD Million) 32
CHAPTER 4. Gene Therapy market – Therapy Area Analysis 32
4.1. Global Gene Therapy Market – Therapy Area Overview 32
4.2. Global Gene Therapy Market Share, by Therapy Area, 2018 & 2025 (USD Million) 33
4.3. Cancer 34
4.3.1. Global Cancer Gene Therapy Market, 2016-2026 (USD Million) 34
4.4. Infectious Diseases 35
4.4.1. Global Infectious Diseases Gene Therapy Market, 2016-2026 (USD Million) 35
4.5. Rheumatoid Arthritis 36
4.5.1. Global Rheumatoid Arthritis Gene Therapy Market, 2016-2026 (USD Million) 36
4.6. Genetic Disorders 37
4.6.1. Global Genetic Disorders Gene Therapy Market, 2016-2026 (USD Million) 37
4.7. Neurological Disorders 38
4.7.1. Global Neurological Disorders Gene Therapy Market, 2016-2026 (USD Million) 38
4.8. Others 39
4.8.1. Global Others Gene Therapy Market, 2016-2026 (USD Million) 39
CHAPTER 5. Gene Therapy market – Regional Analysis 40
5.1. Global Gene Therapy Market Regional Overview 40
5.2. Global Gene Therapy Market Share, by Region, 2018 & 2025 (Value) 40
5.3. North America 42
5.3.1. North America Gene Therapy Market size and forecast, 2016-2026 42
5.3.2. North America Gene Therapy Market, by Country, 2018 & 2025 (USD Million) 42
5.3.3. North America Gene Therapy Market, by Type, 2016-2026 44
5.3.3.1. North America Gene Therapy Market, by Type, 2016-2026 (USD Million) 44
5.3.4. North America Gene Therapy Market, by Vector Type, 2016-2026 45
5.3.4.1. North America Gene Therapy Market, by Vector Type, 2016-2026 (USD Million) 45
5.3.5. North America Gene Therapy Market, by Therapy Area, 2016-2026 46
5.3.5.1. North America Gene Therapy Market, by Therapy Area, 2016-2026 (USD Million) 46
5.3.6. U.S. 47
5.3.6.1. U.S. Market size and forecast, 2016-2026 (USD Million) 47
5.3.7. Canada 48
5.3.7.1. Canada Market size and forecast, 2016-2026 (USD Million) 48
5.3.8. Mexico 49
5.3.8.1. Mexico Market size and forecast, 2016-2026 (USD Million) 49
5.4. Europe 50
5.4.1. Europe Gene Therapy Market size and forecast, 2016-2026 50
5.4.2. Europe Gene Therapy Market, by Country, 2018 & 2025 (USD Million) 50
5.4.3. Europe Gene Therapy Market, by Type, 2016-2026 52
5.4.3.1. Europe Gene Therapy Market, by Type, 2016-2026 (USD Million) 52
5.4.4. Europe Gene Therapy Market, by Vector Type, 2016-2026 53
5.4.4.1. Europe Gene Therapy Market, by Vector Type, 2016-2026 (USD Million) 53
5.4.5. Europe Gene Therapy Market, by Therapy Area, 2016-2026 54
5.4.5.1. Europe Gene Therapy Market, by Therapy Area, 2016-2026 (USD Million) 54
5.4.6. Germany 55
5.4.6.1. Germany Market size and forecast, 2016-2026 (USD Million) 55
5.4.7. France 56
5.4.7.1. France Market size and forecast, 2016-2026 (USD Million) 56
5.4.8. U.K. 57
5.4.8.1. U.K. Market size and forecast, 2016-2026 (USD Million) 57
5.4.9. Italy 58
5.4.9.1. Italy Market size and forecast, 2016-2026 (USD Million) 58
5.4.10. Spain 59
5.4.10.1. Spain Market size and forecast, 2016-2026 (USD Million) 59
5.4.11. Nordic Countries 60
5.4.11.1. Nordic Countries Market size and forecast, 2016-2026 (USD Million) 60
5.4.12. Benelux Union 61
5.4.12.1. Benelux Union Market size and forecast, 2016-2026 (USD Million) 61
5.4.13. Rest of Europe 62
5.4.13.1. Rest of Europe Market size and forecast, 2016-2026 (USD Million) 62
5.5. Asia Pacific 63
5.5.1. Asia Pacific Gene Therapy Market size and forecast, 2016-2026 63
5.5.2. Asia Pacific Gene Therapy Market, by Country, 2018 & 2025 (USD Million) 63
5.5.3. Asia Pacific Gene Therapy Market, by Type, 2016-2026 65
5.5.3.1. Asia Pacific Gene Therapy Market, by Type, 2016-2026 (USD Million) 65
5.5.4. Asia Pacific Gene Therapy Market, by Vector Type, 2016-2026 66
5.5.4.1. Asia Pacific Gene Therapy Market, by Vector Type, 2016-2026 (USD Million) 66
5.5.5. Asia Pacific Gene Therapy Market, by Therapy Area, 2016-2026 67
5.5.5.1. Asia Pacific Gene Therapy Market, by Therapy Area, 2016-2026 (USD Million) 67
5.5.6. China 68
5.5.6.1. China Market size and forecast, 2016-2026 (USD Million) 68
5.5.7. Japan 69
5.5.7.1. Japan Market size and forecast, 2016-2026 (USD Million) 69
5.5.8. India 70
5.5.8.1. India Market size and forecast, 2016-2026 (USD Million) 70
5.5.9. New Zealand 71
5.5.9.1. New Zealand Market size and forecast, 2016-2026 (USD Million) 71
5.5.10. Australia 72
5.5.10.1. Australia Market size and forecast, 2016-2026 (USD Million) 72
5.5.11. South  Korea 73
5.5.11.1. South  Korea Market size and forecast, 2016-2026 (USD Million) 73
5.5.12. South-East Asia 74
5.5.12.1. South-East Asia Market size and forecast, 2016-2026 (USD Million) 74
5.5.13. Rest of Asia Pacific 75
5.5.13.1. Rest of Asia Pacific Market size and forecast, 2016-2026 (USD Million) 75
5.6. Latin America 76
5.6.1. Latin America Gene Therapy Market size and forecast, 2016-2026 76
5.6.2. Latin America Gene Therapy Market, by Country, 2018 & 2025 (USD Million) 76
5.6.3. Latin America Gene Therapy Market, by Type, 2016-2026 78
5.6.3.1. Latin America Gene Therapy Market, by Type, 2016-2026 (USD Million) 78
5.6.4. Latin America Gene Therapy Market, by Vector Type, 2016-2026 79
5.6.4.1. Latin America Gene Therapy Market, by Vector Type, 2016-2026 (USD Million) 79
5.6.5. Latin America Gene Therapy Market, by Therapy Area, 2016-2026 80
5.6.5.1. Latin America Gene Therapy Market, by Therapy Area, 2016-2026 (USD Million) 80
5.6.6. Brazil 81
5.6.6.1. Brazil Market size and forecast, 2016-2026 (USD Million) 81
5.6.7. Argentina 82
5.6.7.1. Argentina Market size and forecast, 2016-2026 (USD Million) 82
5.6.8. Rest of Latin America 83
5.6.8.1. Rest of Latin America Market size and forecast, 2016-2026 (USD Million) 83
5.7. The Middle-East and Africa 84
5.7.1. The Middle-East and Africa Gene Therapy Market size and forecast, 2016-2026 84
5.7.2. The Middle-East and Africa Gene Therapy Market, by Country, 2018 & 2025 (USD Million) 84
5.7.3. The Middle-East and Africa Gene Therapy Market, by Type, 2016-2026 86
5.7.3.1. The Middle-East and Africa Gene Therapy Market, by Type, 2016-2026 (USD Million) 86
5.7.4. The Middle-East and Africa Gene Therapy Market, by Vector Type, 2016-2026 87
5.7.4.1. The Middle-East and Africa Gene Therapy Market, by Vector Type, 2016-2026 (USD Million) 87
5.7.5. The Middle-East and Africa Gene Therapy Market, by Therapy Area, 2016-2026 88
5.7.5.1. The Middle-East and Africa Gene Therapy Market, by Therapy Area, 2016-2026 (USD Million) 88
5.7.6. Saudi Arabia 89
5.7.6.1. Saudi Arabia Market size and forecast, 2016-2026 (USD Million) 89
5.7.7. UAE 90
5.7.7.1. UAE Market size and forecast, 2016-2026 (USD Million) 90
5.7.8. Egypt 91
5.7.8.1. Egypt Market size and forecast, 2016-2026 (USD Million) 91
5.7.9. Kuwait 92
5.7.9.1. Kuwait Market size and forecast, 2016-2026 (USD Million) 92
5.7.10. South Africa 93
5.7.10.1. South Africa Market size and forecast, 2016-2026 (USD Million) 93
5.7.11. Rest of Middle-East Africa 94
5.7.11.1. Rest of Middle-East Africa Market size and forecast, 2016-2026 (USD Million) 94
CHAPTER 6. Gene Therapy market – Competitive Landscape 95
6.1. Competitor Market Share – Revenue 95
6.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players 97
6.3. Strategic Development 98
6.3.1. Acquisitions and Mergers 98
6.3.2. New Products 98
6.3.3. Research & Development Activities 98
CHAPTER 7. Company Profiles 99
7.1. Voyager Therapeutics, Inc. 99
7.1.1. Company Overview 99
7.1.2. Voyager Therapeutics, Inc. Revenue and Gross Margin 99
7.1.3. Product portfolio 100
7.1.4. Recent initiatives 101
7.2. Spark Therapeutics, Inc. 101
7.2.1. Company Overview 101
7.2.2. Spark Therapeutics, Inc. Revenue and Gross Margin 101
7.2.3. Product portfolio 102
7.2.4. Recent initiatives 103
7.3. Sangamo Therapeutics 103
7.3.1. Company Overview 103
7.3.2. Sangamo Therapeutics Revenue and Gross Margin 103
7.3.3. Product portfolio 104
7.3.4. Recent initiatives 105
7.4. Human Stem Cells Institute PJSC 105
7.4.1. Company Overview 105
7.4.2. Human Stem Cells Institute PJSC Revenue and Gross Margin 105
7.4.3. Product portfolio 106
7.4.4. Recent initiatives 107
7.5. Orchard Therapeutics plc 107
7.5.1. Company Overview 107
7.5.2. Orchard Therapeutics plc Revenue and Gross Margin 107
7.5.3. Product portfolio 108
7.5.4. Recent initiatives 109
7.6. Genenta Science 109
7.6.1. Company Overview 109
7.6.2. Genenta Science Revenue and Gross Margin 109
7.6.3. Product portfolio 110
7.6.4. Recent initiatives 111
7.7. Chiesi Farmaceutici S.p.A. 111
7.7.1. Company Overview 111
7.7.2. Chiesi Farmaceutici S.p.A. Revenue and Gross Margin 111
7.7.3. Product portfolio 112
7.7.4. Recent initiatives 113
7.8. Novartis AG 113
7.8.1. Company Overview 113
7.8.2. Novartis AG Revenue and Gross Margin 113
7.8.3. Product portfolio 114
7.8.4. Recent initiatives 115
7.9. GlaxoSmithKline PLC 115
7.9.1. Company Overview 115
7.9.2. GlaxoSmithKline PLC Revenue and Gross Margin 115
7.9.3. Product portfolio 116
7.9.4. Recent initiatives 117
7.10. Gilead Sciences, Inc. 117
7.10.1. Company Overview 117
7.10.2. Gilead Sciences, Inc. Revenue and Gross Margin 117
7.10.3. Product portfolio 118
7.10.4. Recent initiatives 119
7.11. Bristol - Myers Squibb Delta Company Limited 119
7.11.1. Company Overview 119
7.11.2. Bristol - Myers Squibb Delta Company Limited Revenue and Gross Margin 119
7.11.3. Product portfolio 120
7.11.4. Recent initiatives 121
7.12. Advanced Cell & Gene Therapy, LLC 121
7.12.1. Company Overview 121
7.12.2. Advanced Cell & Gene Therapy, LLC Revenue and Gross Margin 121
7.12.3. Product portfolio 122
7.12.4. Recent initiatives 123
7.13. Applied Genetic Technologies Corporation (AGTC) 123
7.13.1. Company Overview 123
7.13.2. Applied Genetic Technologies Corporation (AGTC) Revenue and Gross Margin 123
7.13.3. Product portfolio 124
7.13.4. Recent initiatives 125
7.14. Audentes Therapeutics, Inc. 125
7.14.1. Company Overview 125
7.14.2. Audentes Therapeutics, Inc. Revenue and Gross Margin 125
7.14.3. Product portfolio 126
7.14.4. Recent initiatives 127
7.15. Benitec Biopharma 127
7.15.1. Company Overview 127
7.15.2. Benitec Biopharma Revenue and Gross Margin 127
7.15.3. Product portfolio 128
7.15.4. Recent initiatives 129
7.16. Biogen 129
7.16.1. Company Overview 129
7.16.2. Biogen Revenue and Gross Margin 129
7.16.3. Product portfolio 130
7.16.4. Recent initiatives 131
7.17. Bluebird bio, Inc. 131
7.17.1. Company Overview 131
7.17.2. Bluebird bio, Inc. Revenue and Gross Margin 131
7.17.3. Product portfolio 132
7.17.4. Recent initiatives 133
7.18. Genzyme Corporation 133
7.18.1. Company Overview 133
7.18.2. Genzyme Corporation Revenue and Gross Margin 133
7.18.3. Product portfolio 134
7.18.4. Recent initiatives 135
7.19. Eurofins Genomics 135
7.19.1. Company Overview 135
7.19.2. Eurofins Genomics Revenue and Gross Margin 135
7.19.3. Product portfolio 136
7.19.4. Recent initiatives 137
7.20. Pfizer Inc. 137
7.20.1. Company Overview 137
7.20.2. Pfizer Inc. Revenue and Gross Margin 137
7.20.3. Product portfolio 138
7.20.4. Recent initiatives 139
CHAPTER 8. Gene Therapy — Industry Analysis 140
8.1. Gene Therapy Market – Key Trends 140
8.1.1. Market Drivers 141
8.1.2. Market Restraints 141
8.1.3. Market Opportunities 142
8.2. Value Chain Analysis 143
8.3. Technology Roadmap and Timeline 144
8.4. Gene Therapy Market – Attractiveness Analysis 145
8.4.1. By Type 145
8.4.2. By Vector Type 145
8.4.3. By Therapy Area 146
8.4.4. By Region 148
CHAPTER 9. Marketing Strategy Analysis, Distributors 149
9.1. Marketing Channel 149
9.2. Direct Marketing 150
9.3. Indirect Marketing 150
9.4. Marketing Channel Development Trend 150
9.5. Economic/Political Environmental Change 151
CHAPTER 10. Report Conclusion 152
CHAPTER 11. Research Approach & Methodology 153
11.1. Report Description 153
11.2. Research Scope 154
11.3. Research Methodology 154
11.3.1. Secondary Research 155
11.3.2. Primary Research 156
11.3.3. Models 157
11.3.3.1. Company Share Analysis Model 157
11.3.3.2. Revenue Based Modeling 158
11.3.3.3. Research Limitations 158


                        
            

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode
Single User | $(USD)2900 View Pricing